ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,640.47
      0.24%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cassava Sciences Inc (SAVA)

      7. Cassava Sciences Inc (SAVA) News

      SAVA

      Cassava Sciences (SAVA)

      Cassava Sciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:SAVA
      DateTimeSourceHeadlineSymbolCompany
      05/10/20244:02PMGlobeNewswire Inc.Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of SimufilamNASDAQ:SAVACassava Sciences Inc
      05/08/202411:00AMGlobeNewswire Inc.Cassava Sciences Announces Over $125 Million Raised from Warrant DistributionNASDAQ:SAVACassava Sciences Inc
      05/01/20249:10AMGlobeNewswire Inc.Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQNASDAQ:SAVACassava Sciences Inc
      04/15/20249:20AMGlobeNewswire Inc.Redemption Date Announced for WarrantsNASDAQ:SAVACassava Sciences Inc
      03/25/20249:13AMGlobeNewswire Inc.Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 TrialsNASDAQ:SAVACassava Sciences Inc
      03/04/20249:15AMGlobeNewswire Inc.Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International ConferenceNASDAQ:SAVACassava Sciences Inc
      02/28/20244:01PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SAVACassava Sciences Inc
      02/28/20249:22AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
      02/28/20249:14AMGlobeNewswire Inc.Cassava Sciences Reports Full-year 2023 Financial Results and Corporate UpdatesNASDAQ:SAVACassava Sciences Inc
      02/07/20249:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
      02/07/20249:08AMGlobeNewswire Inc.No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 MonthsNASDAQ:SAVACassava Sciences Inc
      02/01/20244:00PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SAVACassava Sciences Inc
      01/26/20244:23PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SAVACassava Sciences Inc
      01/05/20249:12AMGlobeNewswire Inc.Cassava Sciences Completes Dividend Distribution of Warrants to ShareholdersNASDAQ:SAVACassava Sciences Inc
      01/03/20244:24PMEdgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNASDAQ:SAVACassava Sciences Inc
      01/03/20244:22PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:SAVACassava Sciences Inc
      01/03/20244:18PMEdgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:SAVACassava Sciences Inc
      01/03/20249:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
      01/02/20249:10AMEdgar (US Regulatory)Form 8-A12G - Registration of securities [Section 12(g)]NASDAQ:SAVACassava Sciences Inc
      12/12/20239:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
      12/12/20239:13AMGlobeNewswire Inc.Cassava Sciences Announces Dividend Distribution of Warrants to ShareholdersNASDAQ:SAVACassava Sciences Inc
      12/11/20234:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAVACassava Sciences Inc
      12/08/20235:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
      12/08/20235:04PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
      12/07/20234:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
      12/07/20234:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
      12/07/20234:52PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
      12/07/20234:24PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SAVACassava Sciences Inc
      12/07/20234:01PMGlobeNewswire Inc.Cassava Sciences Appoints Three New Members to its Board of DirectorsNASDAQ:SAVACassava Sciences Inc
      11/07/20239:19AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SAVACassava Sciences Inc
       Showing the most relevant articles for your search:NASDAQ:SAVA